Associate, Department of Biochemistry
Preclinical study involving the screening of chemopreventive & therapeutic efficacy and mechanism of action of orally available transition state analogue inhibitor of human methylthioadenosine phosphorylase (MTAP) as anti-cancer agent in cell culture and mouse xenografts of human head & neck, lung, prostate, breast, colon and cervical cancers by establishing the links between metabolite levels, biochemical changes, CpG island methylation and gene expression patterns of specific cell types.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Golding Building, Room 301
Bronx, NY 10461